Submit Deal

Submit Deal

Cover Image Levi Garraway

Levi Garraway

Head of Product Development and Chief Medical Officer at ROCHE HOLDINGS AG

Manager

Deal Bio

Total Deals1

Valued Deals1

Total Value£ 1.19 B

Avg. Deal Size£ 1.19 B

Market Context

Sort

26 Nov 2024|United States|Pharmaceuticals

Target: POSEIDA THERAPEUTICS

Bidder: ROCHE HOLDINGS AG

10 Service Providers

4 Target | 3 Bidder | 3 Vendor

107 Dealmakers

84 Target | 20 Bidder | 4 Vendor

£ 1.19 B

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite